Discovery is the key to advancing human health. Find out how our leading researchers are pioneering new, breakthrough solutions to some of the world’s most challenging health problems.
Demand from investors raised the opening share price from earlier predictions, a strong indication of confidence in Fusion's potential to create new cancer therapies using nuclear medicine.
Researchers at McMaster University and the University of Toronto have developed a promising immunotherapy treatment for a deadly form of adult brain cancer called glioblastoma.
A huge study of more than 160,000 people in 21 countries has found that women are less likely to have cardiovascular disease, and die of it, than men.
McMaster logo
